Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (484)	6/7/2003 4:28:56 PM
From: Mike McFarland	Respond to of 1336

Some free reading from Nature Genetics, includes a Protemics review article by Aebersold et al nature.com "a bewildering array of tools" That is the only one I've read so far. "Epigenetic regulation..." is going to the printer right now. Also went off and visited the Schreiber lab website to read "Signaling Network Model of Chromatin". Forget it unless you're a chemist, I have no idea what he is getting at after the first read. It was however interesting to see Ariad mentioned along side the likes of Merck and others. Apparently at the time the article was written, 500 of those regulation kits, the dimerizer stuff, had been sent out That seems pretty impressive that so many labs are using it.